HIGHLIGHTS
- who: Yuan Li from the Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Holcombe Blvd, Houston, TX, USA have published the research: GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma, in the Journal: (JOURNAL)
- what: The authors evaluated the expression of GRK3 in primary GAC tissues and paired adjacent normal tissues as well as in peritoneal carcinomatoses (PC) cells from GAC patients. In the present study, for the first time, the authors showed that GRK3 expression was upregulated in GAC tissues and that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.